Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
GPR20 -targeted antibody-drug conjugate
DRUG CLASS:
GPR20 -targeted antibody-drug conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
DS-6157 (3)
DS-6157 (3)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
KIT wild-type
Gastrointestinal Stromal Tumor
KIT wild-type
Gastrointestinal Stromal Tumor
DS-6157
Sensitive: C3 – Early Trials
DS-6157
Sensitive
:
C3
DS-6157
Sensitive: C3 – Early Trials
DS-6157
Sensitive
:
C3
SDHB mutation + NF1 mutation
Gastrointestinal Stromal Tumor
SDHB mutation + NF1 mutation
Gastrointestinal Stromal Tumor
DS-6157
Sensitive: C4 – Case Studies
DS-6157
Sensitive
:
C4
DS-6157
Sensitive: C4 – Case Studies
DS-6157
Sensitive
:
C4
GPR20 expression
Gastrointestinal Stromal Tumor
GPR20 expression
Gastrointestinal Stromal Tumor
DS-6157
Sensitive: D – Preclinical
DS-6157
Sensitive
:
D
DS-6157
Sensitive: D – Preclinical
DS-6157
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login